The closing price of Design Therapeutics Inc (NASDAQ: DSGN) was $3.57 for the day, down -4.55% from the previous closing price of $3.74. In other words, the price has decreased by -$0.1700 from its previous closing price. On the day, 664811 shares were traded.
Ratios:
Our analysis of DSGN’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 29.58 and its Current Ratio is at 29.58. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Piper Sandler on November 14, 2023, Downgraded its rating to Neutral and sets its target price to $6 from $42 previously.
On August 15, 2023, Wedbush Downgraded its rating to Neutral which previously was Outperform and also lowered its target price recommendation from $19 to $6.
SVB Securities Downgraded its Outperform to Market Perform on August 15, 2023, while the target price for the stock was maintained at $6.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 25 ’24 when Schmid John P. bought 17,809 shares for $3.74 per share. The transaction valued at 66,606 led to the insider holds 26,965 shares of the business.
Berger Heather A. bought 1,300 shares of DSGN for $4,866 on Mar 25 ’24. The Director now owns 1,300 shares after completing the transaction at $3.74 per share. On Mar 22 ’24, another insider, Schmid John P., who serves as the Director of the company, bought 9,156 shares for $3.62 each. As a result, the insider paid 33,133 and bolstered with 9,156 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DSGN now has a Market Capitalization of 201.97M and an Enterprise Value of -76.78M.
Stock Price History:
Over the past 52 weeks, DSGN has reached a high of $8.47, while it has fallen to a 52-week low of $1.94. The 50-Day Moving Average of the stock is 2.6434, while the 200-Day Moving Average is calculated to be 3.3920.
Shares Statistics:
DSGN traded an average of 252.57K shares per day over the past three months and 456.32k shares per day over the past ten days. A total of 56.47M shares are outstanding, with a floating share count of 32.84M. Insiders hold about 41.87% of the company’s shares, while institutions hold 44.65% stake in the company. Shares short for DSGN as of Feb 29, 2024 were 2.85M with a Short Ratio of 11.29, compared to 2.43M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 5.09% and a Short% of Float of 8.47%.
Earnings Estimates
The firm’s stock currently is rated by 4 analysts. On average, analysts expect EPS of -$0.27 for the current quarter, with a high estimate of -$0.23 and a low estimate of -$0.31, while EPS last year was -$0.35. The consensus estimate for the next quarter is -$0.29, with high estimates of -$0.24 and low estimates of -$0.35.
Analysts are recommending an EPS of between -$0.97 and -$1.49 for the fiscal current year, implying an average EPS of -$1.18. EPS for the following year is -$1.36, with 4 analysts recommending between -$1.22 and -$1.7.
